“…It was reported to have multiple actions including anti-platelet aggregant (Jantan et al, 2008), anti-angiogenic activities (Ahn et al, 2009), anti-inflammatory (Soromou et al, 2012), anti-oxidant (Kapoor, 2013;Santos et al, 1998;Yu et al, 2009), and antimicrobial (Paintz and Metzner, 1979). Recently, preclinical studies have suggested pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro Liu et al, 2008;Rasul et al, 2013;Shi et al, 2011;Soromou et al, 2012;Wang et al, 2013;Wu et al, 2013). Using a permanent focal cerebral ischemia rat model, pinocembrin improved regional cerebral blood flow and reduced the postischemic damage to the neurovascular unit at the dose level of 3, 10, and 30 mg kg À 1 .…”